Kamel Daoud on Writing, Censorship, and the Paradox of Global Acclaim and Criminalization in Postcolonial Algeria
By
Robert Pogue HarrisonNov 1, 2024
17h ago· 15 min readenInsight
Summary
Algerian novelist Kamel Daoud, sentenced in absentia to three years in prison by an Algerian court for his novel *Houris* (which won the Prix Goncourt in 2024), discusses the paradox of receiving global literary acclaim while being criminalized at home. The article explores the position of the writer in postcolonial Algeria, the tensions between artistic freedom and state censorship, and what it means to be a writer caught between two worlds — celebrated internationally yet silenced domestically.
Source
Key quotes
· 3 pulledON APRIL 21, 2026, an Algerian court sentenced French Algerian writer Kamel Daoud in absentia to three years in prison and imposed a substantial fine. The charge? Not incitement or criminal violence, but writing a novel.
Houris, published by Gallimard in 2024, had just made history: Daoud became the first Algerian author to receive the Prix Goncourt, France's most prestigious literary prize. Yet at home, the book was banned.
Algerian novelist Kamel Daoud discusses the position of the writer in postcolonial Algeria and what it means to receive global acclaim while being criminalized at home.
Algerian novelist Kamel Daoud discusses the position of the writer in postcolonial Algeria and what it means to receive global acclaim while being criminalized at home.
You might also wanna read
Natalie Portman, Philippe Aghion, Kamel Daoud : appel pour une poétesse bloquée à Gaza
ActuaLitté·18d ago
“La poésie arabe exprime des expériences humaines universelles”
ActuaLitté·27d ago
Chowra Makaremi distinguée par le 48e Prix Européen de l’Essai
ActuaLitté·14d ago
Librairies : “Il est grand temps de rallumer les consciences”
ActuaLitté·12d ago
Soupçons d’IA dans un prix littéraire : la revue Granta coupe les ponts
ActuaLitté·14d ago
Une avocate en prison, un amour en exil : Nos vies sauvages, d'Hemley Boum
ActuaLitté·15d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.